Structural and functional implications of ABCC1 variants on clinical statin response

Area of Science:

• Pharmacogenomics
• Molecular biology
• Biochemistry

Background:

• ATP-binding cassette (ABC) proteins are crucial membrane transporters involved in cellular efflux.
• Genetic variations in ABC transporters can affect their function and influence drug response.
• Familial Hypercholesterolemia (FH) management often involves statin therapy, whose efficacy may be compromised by transporter defects.

Purpose of the Study:

• To investigate the impact of specific ABCC1 gene variants on protein structure and interactions with common statins in FH patients.
• To explore potential compensatory mechanisms by other efflux transporters (ABCG2, P-gp) in response to ABCC1 mutations.
• To correlate ABCC1 variants with clinical outcomes in the FH patient cohort.

Main Methods:

• Molecular docking and molecular dynamics simulations were employed to assess protein-ligand interactions.
• The PLANNET model was used for binding affinity, motion, and visual analysis of statin-ABCC1 interactions.
• Analysis included rosuvastatin, atorvastatin, pravastatin, pitavastatin, and lovastatin.
• Subsequent analysis involved ABCG2 and P-gp interactions with statins.

Main Results:

• Missense variants in ABCC1 showed minimal impact on interactions with the studied statins.
• Diminished binding affinities were observed for other efflux pumps (ABCG2, P-gp), suggesting a compensatory role.
• No significant correlation was found between ABCC1 variants and clinical outcomes in the FH patient cohort.

Conclusions:

• ABCC1 variants may not be the primary determinant of statin response in FH patients.
• Compensatory mechanisms involving other drug efflux transporters likely play a significant role in maintaining statin efficacy.
• Further research into the interplay of multiple ABC transporters is warranted for personalized hypercholesterolemia treatment.